» Articles » PMID: 35852018

Microglia Deficiency Accelerates Prion Disease but Does Not Enhance Prion Accumulation in the Brain

Overview
Journal Glia
Specialty Neurology
Date 2022 Jul 19
PMID 35852018
Authors
Affiliations
Soon will be listed here.
Abstract

Prion diseases are transmissible, neurodegenerative disorders associated with misfolding of the prion protein. Previous studies show that reduction of microglia accelerates central nervous system (CNS) prion disease and increases the accumulation of prions in the brain, suggesting that microglia provide neuroprotection by phagocytosing and destroying prions. In Csf1r mice, the deletion of an enhancer within Csf1r specifically blocks microglia development, however, their brains develop normally and show none of the deficits reported in other microglia-deficient models. Csf1r mice were used as a refined model in which to study the impact of microglia-deficiency on CNS prion disease. Although Csf1r mice succumbed to CNS prion disease much earlier than wild-type mice, the accumulation of prions in their brains was reduced. Instead, astrocytes displayed earlier, non-polarized reactive activation with enhanced phagocytosis of neuronal contents and unfolded protein responses. Our data suggest that rather than simply phagocytosing and destroying prions, the microglia instead provide host-protection during CNS prion disease and restrict the harmful activities of reactive astrocytes.

Citing Articles

Reactive astrocytes in prion diseases: Friend or foe?.

Makarava N, Kushwaha R, Baskakov I PLoS Pathog. 2024; 20(6):e1012286.

PMID: 38900746 PMC: 11189187. DOI: 10.1371/journal.ppat.1012286.


Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease.

Bradford B, Walmsley-Rowe L, Reynolds J, Verity N, Mabbott N Sci Rep. 2024; 14(1):13749.

PMID: 38877012 PMC: 11178777. DOI: 10.1038/s41598-024-63464-3.


NG2 glia protect against prion neurotoxicity by inhibiting microglia-to-neuron prostaglandin E2 signaling.

Liu Y, Guo J, Matoga M, Korotkova M, Jakobsson P, Aguzzi A Nat Neurosci. 2024; 27(8):1534-1544.

PMID: 38802591 PMC: 11303249. DOI: 10.1038/s41593-024-01663-x.


Interactions between Cytokines and the Pathogenesis of Prion Diseases: Insights and Implications.

Assis-de-Lemos G, Moura-do-Nascimento R, Amaral-do-Nascimento M, Miceli A, Vieira T Brain Sci. 2024; 14(5).

PMID: 38790392 PMC: 11117815. DOI: 10.3390/brainsci14050413.


The Role of Glial Cells in Neurobiology and Prion Neuropathology.

Hay A, Popichak K, Moreno J, Zabel M Cells. 2024; 13(10.

PMID: 38786054 PMC: 11119027. DOI: 10.3390/cells13100832.


References
1.
Brown K, Mabbott N . Evidence of subclinical prion disease in aged mice following exposure to bovine spongiform encephalopathy. J Gen Virol. 2013; 95(Pt 1):231-243. DOI: 10.1099/vir.0.058958-0. View

2.
Guo L, Bertola D, Takanohashi A, Saito A, Segawa Y, Yokota T . Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation. Am J Hum Genet. 2019; 104(5):925-935. PMC: 6507048. DOI: 10.1016/j.ajhg.2019.03.004. View

3.
Atarashi R, Sano K, Satoh K, Nishida N . Real-time quaking-induced conversion: a highly sensitive assay for prion detection. Prion. 2011; 5(3):150-3. PMC: 3226039. DOI: 10.4161/pri.5.3.16893. View

4.
Pridans C, Raper A, Davis G, Alves J, Sauter K, Lefevre L . Pleiotropic Impacts of Macrophage and Microglial Deficiency on Development in Rats with Targeted Mutation of the Locus. J Immunol. 2018; 201(9):2683-2699. PMC: 6196293. DOI: 10.4049/jimmunol.1701783. View

5.
Maignien T, Shakweh M, Calvo P, Marce D, Sales N, Fattal E . Role of gut macrophages in mice orally contaminated with scrapie or BSE. Int J Pharm. 2005; 298(2):293-304. DOI: 10.1016/j.ijpharm.2005.02.042. View